Wuhan Humanwell Innovative Drug Research And Development Center Limited Company
Clinical trials sponsored by Wuhan Humanwell Innovative Drug Research And Development Center Limited Company, explained in plain language.
-
New oral cancer drug begins first human safety testing
Disease control Recruiting nowThis is the first human study of an experimental oral medication called HW071021 for people with advanced solid tumors that have stopped responding to standard treatments. The trial will test increasing doses to find the safest amount and see how the body processes the drug. Rese…
Phase: PHASE1 • Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company • Aim: Disease control
Last updated Apr 04, 2026 03:51 UTC
-
First human tests begin for potential IBD treatment
Knowledge-focused Recruiting nowThis early-stage study aims to determine if a new drug called HW201877 is safe for people. Researchers will give the drug to 104 healthy volunteers to check for side effects and see how the body processes it. The study will test different doses and see if taking the drug with foo…
Phase: PHASE1 • Sponsor: Wuhan Humanwell Innovative Drug Research and Development Center Limited Company • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC